GSA Capital Partners’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Buy
525,896
+190,199
+57% +$174K 0.03% 1080
2026
Q1
$413K Buy
335,697
+96,922
+41% +$168K 0.03% 1039
2025
Q4
$685K Buy
+238,775
New +$662K 0.06% 606
2024
Q3
Sell
-57,032
Closed -$311K 1676
2024
Q2
$311K Buy
+57,032
New +$359K 0.02% 1256
2022
Q4
Sell
-20,683
Closed -$321K 1559
2022
Q3
$321K Buy
+20,683
New +$455K 0.04% 887

Other funds holding DH

GSA Capital Partners's DH Position: Q2 2026 in Review

GSA Capital Partners increased its Definitive Healthcare (DH) stake by 57% in Q2 2026, buying an estimated $174K and bringing the position to 525,896 shares worth $437K. The position accounts for 0.03% of the portfolio, ranked #1080.

GSA Capital Partners first reported a position in DH in Q3 2022 and has held it in 5 quarters since. The position peaked at $685K in Q4 2025. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • GSA Capital Partners held 525,896 shares of Definitive Healthcare worth $437K as of Q2 2026.
  • GSA Capital Partners bought 190,199 Definitive Healthcare shares in Q2 2026, an estimated $174K.
  • Definitive Healthcare made up 0.03% of GSA Capital Partners's portfolio in Q2 2026, its #1080 holding.
  • GSA Capital Partners first reported a position in Definitive Healthcare in Q3 2022 and has held it in 5 quarters since.
  • GSA Capital Partners's Definitive Healthcare position peaked at $685K in Q4 2025.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.